Blog

Patrick Hwu: Rick Scott and Gus Bilirakis have both been unwavering supporters of Moffitt Cancer Center

Collage of Patrick Hwu, Gus Bilirakis and Rick Scott

Jun 25, 2024, 15:42

Patrick Hwu: Rick Scott and Gus Bilirakis have both been unwavering supporters of Moffitt Cancer Center

Patrick Hwu shared a post LinkedIn:

“Senator Rick Scott and Representative Gus Bilirakis have both been unwavering supporters of Moffitt Cancer Center’s mission to prevent and cure cancer. Today, they joined the Moffitt team and biotech industry leaders to tour SperosFL, our global innovation center for science, technology and health care in Pasco County.

During the tour, they visited construction sites for Moffitt’s proton therapy center, research innovation center, and outpatient clinic. Speros aims to bring together multiple disciplines in a way like never before, and will accelerate scientific discovery in cell and gene therapy, immunotherapy and more.

A big thank you to all who joined us this morning! I am so inspired by the momentum around this new campus and the hope it will bring to so many. Together we are positioning Florida as a leader in health and life sciences, and through our collective efforts will save more lives today and tomorrow. ”

Source: Patrick Hwu/LinkedIn

Dr. Patrick Hwu, MD, currently serves as the President and CEO of Moffitt Cancer Center. With a focus on understanding the dynamics between tumors and the immune system, Dr. Hwu’s research has been pivotal in advancing gene-modified T-cell therapy.

He notably contributed seminal work on the development of the first chimeric antigen receptor aimed at combating cancer. His research portfolio extends to vaccines, adoptive T-cell therapies, and mechanisms of immune resistance.

Before joining, Dr. Hwu held numerous leadership roles at The University of Texas MD Anderson Cancer Center for over 17 years. Notably, he served as the inaugural Chairman of the Department of Melanoma Medical Oncology in 2003, as well as the Associate Director of the Center for Cancer Immunology Research.

Additionally, he chaired the Department of Sarcoma Medical Oncology, demonstrating his commitment to advancing cancer treatment and research.